Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials.
Saved in:
| Title: | Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials. |
|---|---|
| Authors: | Zhang, Wen-Jiao1 (AUTHOR), Qiao, Xuan1 (AUTHOR), Liang, Xi-Ying1 (AUTHOR), Li, Yan1 (AUTHOR), Yang, Rong-Rong1 (AUTHOR), Wang, Zhi-Lu2 (AUTHOR) wangzhl@lzu.edu.cn |
| Source: | Platelets. 2021, Vol. 32 Issue 5, p582-590. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09537104 |
|---|---|
| DOI: | 10.1080/09537104.2020.1786039 |
